Dopamine receptor polymorphisms and drug response in schizophrenia

被引：13
作者：
Scharfetter, J [1 ]
机构：
[1] Univ Klin Psychiat, Abt Allgemeine Psychiat, A-1090 Vienna, Austria
来源：
PHARMACOGENOMICS | 2001年 / 2卷 / 03期
关键词：
association; dopamine; pharmacogenetic; response; schizophrenia;
D O I：
10.1517/14622416.2.3.251
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The elucidation of the assumed genetic contribution to the predisposition towards schizophrenia is a scientifically challenging enterprise with considerable impact on therapeutic possibilities. A pharmacogenetic approach, targeted to the clinical response to medication, provides a promising alternative as a means of investigation, with the prospect of gaining knowledge about the disease and of developing an individually tailored medical treatment. This review will focus on dopamine receptor genes which have, due to the dopamine hypothesis of schizophrenia, been a prime target in pharmacogenetic studies of schizophrenia. The current status of the studies results will be displayed and future prospects will be discussed.
引用
收藏
页码：251 / 261
页数：11
相关论文
共 50 条
[31]   Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Ser311Cys Polymorphisms of the Dopamine D2-Receptor Gene and Schizophrenia [J].
Itokawa, Masanari ;
Arinami, Tadao ;
Toru, Michio .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 114 (01) :1-5
[32]   Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia [J].
Xing, QH ;
Wu, SN ;
Lin, ZG ;
Li, HF ;
Yang, JD ;
Feng, GY ;
Wang, MT ;
Yang, WW ;
He, L .
SCHIZOPHRENIA RESEARCH, 2003, 65 (01) :9-14
[33]   Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia [J].
Matsumoto, C ;
Shinkai, T ;
De Luca, V ;
Hwang, R ;
Hori, H ;
Lanktree, M ;
Ohmori, O ;
Kennedy, JL ;
Nakamura, J .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (02) :245-253
[34]   Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia [J].
Hori, H ;
Ohmori, O ;
Shinkai, T ;
Kojima, H ;
Nakamura, J .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (02) :176-178
[35]   The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients [J].
Xing, Qinghe ;
Qian, Xueqing ;
Li, Huafang ;
Wong, Shiming ;
Wu, Shengnan ;
Feng, Guoyin ;
Duan, Shiwei ;
Xu, Mingqing ;
Gao, Rui ;
Qin, Wei ;
Gao, Jianjun ;
Meng, Junwei ;
He, Lin .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05) :631-637
[36]   Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations [J].
Hwang, R ;
Shinkai, T ;
De Luca, V ;
Müller, DJ ;
Ni, XQ ;
Macciardi, F ;
Potkin, S ;
Lieberman, JA ;
Meltzer, HY ;
Kennedy, JL .
PSYCHOPHARMACOLOGY, 2005, 181 (01) :179-187
[37]   Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations [J].
Rudi Hwang ;
Takahiro Shinkai ;
Vincenzo De Luca ;
Daniel J. Müller ;
Xingqun Ni ;
Fabio Macciardi ;
Steven Potkin ;
Jeffrey A. Lieberman ;
Herbert Y. Meltzer ;
James L. Kennedy .
Psychopharmacology, 2005, 181 :179-187
[38]   Dopamine in schizophrenia [J].
Hietala, J ;
Syvalahti, E .
ANNALS OF MEDICINE, 1996, 28 (06) :557-561
[39]   Relationship between adverse effects of antipsychotic treatment and dopamine D2 receptor polymorphisms in patients with schizophrenia [J].
R Kaiser ;
P-B Tremblay ;
F Klufmöller ;
I Roots ;
J Brockmöller .
Molecular Psychiatry, 2002, 7 :695-705
[40]   Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene (DRD4) with schizophrenia and personality traits [J].
H. Mitsuyasu ;
N. Hirata ;
Y. Sakai ;
H. Shibata ;
Y. Takeda ;
H. Ninomiya ;
H. Kawasaki ;
N. Tashiro ;
Y. Fukumaki .
Journal of Human Genetics, 2001, 46 :26-31
12345